Global Neuroprotective Agents Market Growth (Status and Outlook) 2019-2024

January 2019 | 119 pages | ID: G1522E8358AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Neuroprotective agents are medications that can alter the course of metabolic events after the onset of ischemia and therefore have the potential to reduce stroke damage.

According to this study, over the next five years the Neuroprotective Agents market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Neuroprotective Agents business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Neuroprotective Agents market by product type, application, key companies and key regions.

This study considers the Neuroprotective Agents value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

• Cerebrovascular Diseases
• Neurodegenerative Disorders
• Traumatic CNS Injuries

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

• Hospitals
• Clinics
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Genervon Biopharmaceuticals
• NeuroVive Pharmaceutical
• Ceregene
• Neuren Pharmaceuticals
• Allon Therapeutics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Neuroprotective Agents market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
• To understand the structure of Neuroprotective Agents market by identifying its various subsegments.
• Focuses on the key global Neuroprotective Agents players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Neuroprotective Agents with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Neuroprotective Agents submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2019-2024 GLOBAL NEUROPROTECTIVE AGENTS MARKET REPORT (STATUS AND OUTLOOK)

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Neuroprotective Agents Market Size 2014-2024
  2.1.2 Neuroprotective Agents Market Size CAGR by Region
2.2 Neuroprotective Agents Segment by Type
  2.2.1 Cerebrovascular Diseases
  2.2.2 Neurodegenerative Disorders
  2.2.3 Ophthalmic Diseases
  2.2.4 Traumatic CNS Injuries
2.3 Neuroprotective Agents Market Size by Type
  2.3.1 Global Neuroprotective Agents Market Size Market Share by Type (2014-2019)
  2.3.2 Global Neuroprotective Agents Market Size Growth Rate by Type (2014-2019)
2.4 Neuroprotective Agents Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Neuroprotective Agents Market Size by Application
  2.5.1 Global Neuroprotective Agents Market Size Market Share by Application (2014-2019)
  2.5.2 Global Neuroprotective Agents Market Size Growth Rate by Application (2014-2019)

3 GLOBAL NEUROPROTECTIVE AGENTS BY PLAYERS

3.1 Global Neuroprotective Agents Market Size Market Share by Players
  3.1.1 Global Neuroprotective Agents Market Size by Players (2017-2019)
  3.1.2 Global Neuroprotective Agents Market Size Market Share by Players (2017-2019)
3.2 Global Neuroprotective Agents Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NEUROPROTECTIVE AGENTS BY REGIONS

4.1 Neuroprotective Agents Market Size by Regions
4.2 Americas Neuroprotective Agents Market Size Growth
4.3 APAC Neuroprotective Agents Market Size Growth
4.4 Europe Neuroprotective Agents Market Size Growth
4.5 Middle East & Africa Neuroprotective Agents Market Size Growth

5 AMERICAS

5.1 Americas Neuroprotective Agents Market Size by Countries
5.2 Americas Neuroprotective Agents Market Size by Type
5.3 Americas Neuroprotective Agents Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Neuroprotective Agents Market Size by Countries
6.2 APAC Neuroprotective Agents Market Size by Type
6.3 APAC Neuroprotective Agents Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Neuroprotective Agents by Countries
7.2 Europe Neuroprotective Agents Market Size by Type
7.3 Europe Neuroprotective Agents Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Neuroprotective Agents by Countries
8.2 Middle East & Africa Neuroprotective Agents Market Size by Type
8.3 Middle East & Africa Neuroprotective Agents Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL NEUROPROTECTIVE AGENTS MARKET FORECAST

10.1 Global Neuroprotective Agents Market Size Forecast (2019-2024)
10.2 Global Neuroprotective Agents Forecast by Regions
  10.2.1 Global Neuroprotective Agents Forecast by Regions (2019-2024)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Neuroprotective Agents Forecast by Type
10.8 Global Neuroprotective Agents Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Genervon Biopharmaceuticals
  11.1.1 Company Details
  11.1.2 Neuroprotective Agents Product Offered
  11.1.3 Genervon Biopharmaceuticals Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2019)
  11.1.4 Main Business Overview
  11.1.5 Genervon Biopharmaceuticals News
11.2 NeuroVive Pharmaceutical
  11.2.1 Company Details
  11.2.2 Neuroprotective Agents Product Offered
  11.2.3 NeuroVive Pharmaceutical Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2019)
  11.2.4 Main Business Overview
  11.2.5 NeuroVive Pharmaceutical News
11.3 Ceregene
  11.3.1 Company Details
  11.3.2 Neuroprotective Agents Product Offered
  11.3.3 Ceregene Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2019)
  11.3.4 Main Business Overview
  11.3.5 Ceregene News
11.4 Neuren Pharmaceuticals
  11.4.1 Company Details
  11.4.2 Neuroprotective Agents Product Offered
  11.4.3 Neuren Pharmaceuticals Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2019)
  11.4.4 Main Business Overview
  11.4.5 Neuren Pharmaceuticals News
11.5 Allon Therapeutics
  11.5.1 Company Details
  11.5.2 Neuroprotective Agents Product Offered
  11.5.3 Allon Therapeutics Neuroprotective Agents Revenue, Gross Margin and Market Share (2017-2019)
  11.5.4 Main Business Overview
  11.5.5 Allon Therapeutics News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Neuroprotective Agents
Figure Neuroprotective Agents Report Years Considered
Figure Market Research Methodology
Figure Global Neuroprotective Agents Market Size Growth Rate 2014-2024 ($ Millions)
Table Neuroprotective Agents Market Size CAGR by Region 2014-2024 ($ Millions)
Table Major Players of Cerebrovascular Diseases
Table Major Players of Neurodegenerative Disorders
Table Major Players of Ophthalmic Diseases
Table Major Players of Traumatic CNS Injuries
Table Market Size by Type (2014-2019) ($ Millions)
Table Global Neuroprotective Agents Market Size Market Share by Type (2014-2019)
Figure Global Neuroprotective Agents Market Size Market Share by Type (2014-2019)
Figure Global Cerebrovascular Diseases Market Size Growth Rate
Figure Global Neurodegenerative Disorders Market Size Growth Rate
Figure Global Ophthalmic Diseases Market Size Growth Rate
Figure Global Traumatic CNS Injuries Market Size Growth Rate
Figure Neuroprotective Agents Consumed in Hospitals
Figure Global Neuroprotective Agents Market: Hospitals (2014-2019) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Neuroprotective Agents Consumed in Clinics
Figure Global Neuroprotective Agents Market: Clinics (2014-2019) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Neuroprotective Agents Consumed in Others
Figure Global Neuroprotective Agents Market: Others (2014-2019) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Neuroprotective Agents Market Size by Application (2014-2019) ($ Millions)
Table Global Neuroprotective Agents Market Size Market Share by Application (2014-2019)
Figure Global Neuroprotective Agents Market Size Market Share by Application (2014-2019)
Figure Global Neuroprotective Agents Market Size in Hospitals Growth Rate
Figure Global Neuroprotective Agents Market Size in Clinics Growth Rate
Figure Global Neuroprotective Agents Market Size in Others Growth Rate
Table Global Neuroprotective Agents Revenue by Players (2017-2019) ($ Millions)
Table Global Neuroprotective Agents Revenue Market Share by Players (2017-2019)
Figure Global Neuroprotective Agents Revenue Market Share by Players in 2018
Table Global Neuroprotective Agents Key Players Head office and Products Offered
Table Neuroprotective Agents Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Neuroprotective Agents Market Size by Regions 2014-2019 ($ Millions)
Table Global Neuroprotective Agents Market Size Market Share by Regions 2014-2019
Figure Global Neuroprotective Agents Market Size Market Share by Regions 2014-2019
Figure Americas Neuroprotective Agents Market Size 2014-2019 ($ Millions)
Figure APAC Neuroprotective Agents Market Size 2014-2019 ($ Millions)
Figure Europe Neuroprotective Agents Market Size 2014-2019 ($ Millions)
Figure Middle East & Africa Neuroprotective Agents Market Size 2014-2019 ($ Millions)
Table Americas Neuroprotective Agents Market Size by Countries (2014-2019) ($ Millions)
Table Americas Neuroprotective Agents Market Size Market Share by Countries (2014-2019)
Figure Americas Neuroprotective Agents Market Size Market Share by Countries in 2018
Table Americas Neuroprotective Agents Market Size by Type (2014-2019) ($ Millions)
Table Americas Neuroprotective Agents Market Size Market Share by Type (2014-2019)
Figure Americas Neuroprotective Agents Market Size Market Share by Type in 2018
Table Americas Neuroprotective Agents Market Size by Application (2014-2019) ($ Millions)
Table Americas Neuroprotective Agents Market Size Market Share by Application (2014-2019)
Figure Americas Neuroprotective Agents Market Size Market Share by Application in 2018
Figure United States Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Canada Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Mexico Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Table APAC Neuroprotective Agents Market Size by Countries (2014-2019) ($ Millions)
Table APAC Neuroprotective Agents Market Size Market Share by Countries (2014-2019)
Figure APAC Neuroprotective Agents Market Size Market Share by Countries in 2018
Table APAC Neuroprotective Agents Market Size by Type (2014-2019) ($ Millions)
Table APAC Neuroprotective Agents Market Size Market Share by Type (2014-2019)
Figure APAC Neuroprotective Agents Market Size Market Share by Type in 2018
Table APAC Neuroprotective Agents Market Size by Application (2014-2019) ($ Millions)
Table APAC Neuroprotective Agents Market Size Market Share by Application (2014-2019)
Figure APAC Neuroprotective Agents Market Size Market Share by Application in 2018
Figure China Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Japan Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Korea Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Southeast Asia Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure India Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Australia Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Table Europe Neuroprotective Agents Market Size by Countries (2014-2019) ($ Millions)
Table Europe Neuroprotective Agents Market Size Market Share by Countries (2014-2019)
Figure Europe Neuroprotective Agents Market Size Market Share by Countries in 2018
Table Europe Neuroprotective Agents Market Size by Type (2014-2019) ($ Millions)
Table Europe Neuroprotective Agents Market Size Market Share by Type (2014-2019)
Figure Europe Neuroprotective Agents Market Size Market Share by Type in 2018
Table Europe Neuroprotective Agents Market Size by Application (2014-2019) ($ Millions)
Table Europe Neuroprotective Agents Market Size Market Share by Application (2014-2019)
Figure Europe Neuroprotective Agents Market Size Market Share by Application in 2018
Figure Germany Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure France Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure UK Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Italy Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Russia Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Spain Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Table Middle East & Africa Neuroprotective Agents Market Size by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Neuroprotective Agents Market Size Market Share by Countries (2014-2019)
Figure Middle East & Africa Neuroprotective Agents Market Size Market Share by Countries in 2018
Table Middle East & Africa Neuroprotective Agents Market Size by Type (2014-2019) ($ Millions)
Table Middle East & Africa Neuroprotective Agents Market Size Market Share by Type (2014-2019)
Figure Middle East & Africa Neuroprotective Agents Market Size Market Share by Type in 2018
Table Middle East & Africa Neuroprotective Agents Market Size by Application (2014-2019) ($ Millions)
Table Middle East & Africa Neuroprotective Agents Market Size Market Share by Application (2014-2019)
Figure Middle East & Africa Neuroprotective Agents Market Size Market Share by Application in 2018
Figure Egypt Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure South Africa Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Israel Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Turkey Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure GCC Countries Neuroprotective Agents Market Size Growth 2014-2019 ($ Millions)
Figure Global Neuroprotective Agents arket Size Forecast (2019-2024) ($ Millions)
Table Global Neuroprotective Agents Market Size Forecast by Regions (2019-2024) ($ Millions)
Table Global Neuroprotective Agents Market Size Market Share Forecast by Regions
Figure Americas Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure APAC Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Europe Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Middle East & Africa Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure United States Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Canada Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Mexico Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Brazil Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure China Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Japan Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Korea Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Southeast Asia Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure India Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Australia Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Germany Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure France Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure UK Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Italy Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Russia Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Spain Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Egypt Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure South Africa Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Israel Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure Turkey Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Figure GCC Countries Neuroprotective Agents Market Size 2019-2024 ($ Millions)
Table Global Neuroprotective Agents Market Size Forecast by Type (2019-2024) ($ Millions)
Table Global Neuroprotective Agents Market Size Market Share Forecast by Type (2019-2024)
Table Global Neuroprotective Agents Market Size Forecast by Application (2019-2024) ($ Millions)
Table Global Neuroprotective Agents Market Size Market Share Forecast by Application (2019-2024)
Table Genervon Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Genervon Biopharmaceuticals Neuroprotective Agents Revenue and Gross Margin (2017-2019)
Figure Genervon Biopharmaceuticals Neuroprotective Agents Market Share (2017-2019)
Table NeuroVive Pharmaceutical Basic Information, Head Office, Major Market Areas and Its Competitors
Table NeuroVive Pharmaceutical Neuroprotective Agents Revenue and Gross Margin (2017-2019)
Figure NeuroVive Pharmaceutical Neuroprotective Agents Market Share (2017-2019)
Table Ceregene Basic Information, Head Office, Major Market Areas and Its Competitors
Table Ceregene Neuroprotective Agents Revenue and Gross Margin (2017-2019)
Figure Ceregene Neuroprotective Agents Market Share (2017-2019)
Table Neuren Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Neuren Pharmaceuticals Neuroprotective Agents Revenue and Gross Margin (2017-2019)
Figure Neuren Pharmaceuticals Neuroprotective Agents Market Share (2017-2019)
Table Allon Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Allon Therapeutics Neuroprotective Agents Revenue and Gross Margin (2017-2019)
Figure Allon Therapeutics Neuroprotective Agents Market Share (2017-2019)